A Pilot Study of Oral Sumatriptan as Intermittent Prophylaxis of Menstruation-Related Migraine
Neurol 51:307-309, Newman,L.C.,et al, 1998
Inappropriate Use of Sumatriptan:Population Based Register and Interview Study
BMJ 316:1352-1353, Gaist,D.,et al, 1998
Pregnancy Outcome Following First Trimester Exposure to Sumatriptan
Neurol 51:581-583, Shuhaiber,S.,et al, 1998
Sumatriptan Injection Reduces Productivity Loss During a Migraine Attack
Arch Int Med 158:1013-1018, Cady,R.C.,et al, 1998
Cabergoline Treatment of Early Parkinson's Disease:First Yr of Trtm Comparison of Cabergoline & Levodopa
Neurol 48:363-368, Rinne,U.K.,et al, 1997
Sumatriptan Nasal Spray for Acute Treatment of Migraine, Results of Two Clin Studies
Neurol 49:1225-1230, 11931997., Ryan,R.,et al, 1997
Optimizing the Dose of Zolmitriptan (Zomig, *311C90) for the Acute Treatment of Migraine
Neurol 49:1210-1218, 11931997., Rapoport,A.M.,et al, 1997
Clinical Efficacy and Tolerability of 2. 5Mg Zolmitriptan for the Acute Treatment of Migraine
Neurol 49:1219-1225, Solomon,G.D.,et al, 1997
Naratriptan is Effective and Well Tolerated in the Acute Treatment of Migraine
Neurol 49:1485-1490, Mathew,T.,et al, 1997
Characteristics and Determinants of Sumatriptan-Associated Chest Pain
Arch Neurol 54:1387-1392, Ottervanger,J.P.,et al, 1997
Lifestyle-Associated Risk Factors for Acute Brain Infarction Among Persons of Working Age
Stroke 28:26-30, Haapaniemi,H.,et al, 1997
Continuous Bromocriptine Therapy in Menstrual Migraine
Neurol 48:101-102, Herzog,A.G., 1997
Nasal Benzodiazepines for Management of Acute Childhood Seizures
Lancet 349:222-223, Wallace,S.J., 1997
Pharmacological Management of Alcohol Withdrawal
JAMA 278:144-151, Mayo-Smith,M.F., 1997
The Alcohol Withdrawal Syndrome
Lancet 349:1897-1900, Hall,W.&Zador,D., 1997
Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997
Sumatriptan for Migraine Attacks in Children:A Randomized Placebo-Controlled Study
Neurol 48:1100-1103, Hamalainen,M.L.,et al, 1997
Distinction of Idiopathic Parkinson's Dis from Multi-Syst Atrophy by Stim of Growth-Hormone Release w Clonidine
Lancet 349:1877-1881, Kimber,J.R.,et al, 1997
Safety and Efficacy of Pramipexole in Early Parkinson Disease
Parkinson Study Group, JAMA 278:125-1301997., , 1997
Clinical Evaluation of Pramipexole in Advanced Parkinson's Disease
Neurol 49:162-168, Lieberman,A.,et al, 1997
Efficacy of Pramipexole, A Novel Dopamine Agonist, As Monotherapy in Mild to Moderate Parkinson's Disease
Neurol 49:724-728, Shannon,K.M.,et al, 1997
Pharmacologic Profile of Ropinirole:A Nonergoline Dopamine Agonist
Neurol 49:558-562, Tulloch,I.F., 1997
Ropinirole for the Treatment of Early Parkinson's Disease
Neurol 49:393-399, Adler,C.H.,et al, 1997
Use of Low-Dose Oral Contraceptives and Stroke in Young Women
Ann Int Med 127:596-603, Schwartz,S.M.,et al, 1997
Case-Control Study of Oral Contraceptives & Risk of Thromboembolic Stroke
BMJ 315:1502-1504, Heinermann,L.A.J.,et al, 1997
Double-Blind Comparison of Pramipexole & Bromocriptine Trtm with Placebo in Advanced Parkinson's Disease
Neurol 49:1060-1065, Guttman,M.,et al, 1997
Chiasmal Herniation as a Complication of Bromocriptine Therapy
J Neuro-Ophthalmol 16:252-257, Taxel,P.,et al, 1996
Restless Legs Syndrome:Clinicoetiologic Correlates
Neurol 47:1435-1441, Ondo,W.&Jankovic,J., 1996
Use of Sumatriptan in Post-Ictal Migraine Headache
Neurol 47:1104, Jacob,J.,et al, 1996
A Double-Blind Study of Subcut Dihydroergotamine vs Subcut Sumatriptan in Treat of Acute Migraine
Arch Neurol 53:180-184, Winner,P.,et al, 1996
Rizatriptan vs Sumatriptan in Acute Trmt of Migraine. Dutch/US Rizatriptan Study Group
Arch Neurol 53:1132-1137, Visser,W.H.,et al, 1996
Long-term Prognosis in Cerebral Venous Thrombosis:Follow-up of 77 Patients
Stroke 27:243-246, Preter,M.,et al, 1996
Stroke in Users of Low-Dose Oral Contraceptives
NEJM 335:8-15, 531996., Petitti,D.B.,et al, 1996
Ischaemic Stroke and Combined Oral Contraceptives:Results of an International, Multicentre, Case-Control Study
Lancet 348:498-505, Poulter,N.R.,et al, 1996
Bromocriptine and Postpartum Cerebral Angiopathy:A Causal Relationship
Neurol 46:1754-1756, Comabella,M.,et al, 1996
Cerebral Venous Sinus Thrombosis Associated with Factor V Gene Mutation
JNNP 61:204-205, Kimber,T.,et al, 1996
Antiepileptic Medication and Oral Contraceptive Interactions:A National Survey of Neurologists and Obstetricians
Neurol 46:1534-1539, Krauss,G.L.,et al, 1996
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
History of Migraine and Risk of Cerebral Ischaemia in Young Adults
Lancet 347:1503-1506, Carolei,A.,et al, 1996
Easy Therapeutical Management of Sumatriptan-Induced Daily Headache
Neurol 47:297-298, Gobel,H.,et al, 1996
Diagnosis and Management of Migraine
BMJ 312:1279-1283, Goadsby,P.J.&Olesen,J., 1996
A Comparison of Subcutaneous Sumatriptan and Dihydroergotamine Nasal Spray in the Acute Treatment of Migraine
Neurol 47:361-365, Touchon,J.,et al, 1996
Sumatriptan in Clinical Practice:A 2-year Review of 453 Migraine Patients
Neurol 47:46-51, Visser,W.H.,et al, 1996
Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996
Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996
Medication for Children with Attentional Disorders
Pediatrics 98:301-304, Perrin,J.,et al, 1996
New Antiepileptic Drugs
NEJM 334:1583-1590, Dichter,M.A.&Brodie,M.J., 1996
Lorazepam and Midazolam in the Intensive Care Unit:A Randomized, Prospective, Multicenter Study of Hemodynamics, Oxygen Transport, Efficacy, and Cost
Crit Care Med 24:222-228, Cernaianu A.C.,et al, 1996
Primary Prevention of Stroke
NEJM 333:1392-1400, Bronner,L.L.,et al, 1995
The Poisoned Patient with Altered Consciousness, Controversies in the Use of a"Coma Cocktail"
JAMA 274:562-569, Hoffman,R.S.&Goldfrank,L.R., 1995